Upstream Bio, Inc

Newest shelf

No limit

S-3ASR of 2025-11-05. An automatic shelf: the form sets no dollar limit. 1 prospectus supplement filed under it since. S-3ASR ↗

At the market

$150.0M

Leerink Partners, agreement of 2026-03-26. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-11 is not read yet.

Cash

7.7 quarters

$261.3M on 2026-06-30 ÷ $34.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗